Yield10 Retained Earnings vs Long Term Investments Analysis

YTEN Stock

USD 0.24 0.01 4.35%

Yield10 Bioscience financial indicator trend analysis is more than just analyzing Yield10 Bioscience current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Yield10 Bioscience is a good investment. Please check the relationship between Yield10 Bioscience Retained Earnings and its Long Term Investments accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Yield10 Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.

Retained Earnings vs Long Term Investments

Retained Earnings vs Long Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Yield10 Bioscience Retained Earnings account and Long Term Investments. At this time, the significance of the direction appears to have pay attention.

The correlation between Yield10 Bioscience's Retained Earnings and Long Term Investments is -0.74. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Long Term Investments in the same time period over historical financial statements of Yield10 Bioscience, assuming nothing else is changed. The correlation between historical values of Yield10 Bioscience's Retained Earnings and Long Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Yield10 Bioscience are associated (or correlated) with its Long Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Investments has no effect on the direction of Retained Earnings i.e., Yield10 Bioscience's Retained Earnings and Long Term Investments go up and down completely randomly.

Correlation Coefficient

-0.74

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Long Term Investments

Long Term Investments is an item on the asset side of Yield10 Bioscience balance sheet that represents investments Yield10 Bioscience intends to hold for over a year. Yield10 Bioscience long term investments may include different instruments such as stocks, bonds, real estate and cash.

Most indicators from Yield10 Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Yield10 Bioscience current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Yield10 Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.At this time, Yield10 Bioscience's Selling General Administrative is very stable compared to the past year. As of the 1st of May 2024, Discontinued Operations is likely to grow to about 1.9 M, while Issuance Of Capital Stock is likely to drop about 5 M.

	2021	2022	2023	2024 (projected)
Cost Of Revenue	578K	656K	290K	275.5K
Research Development	6.2M	7.8M	8.3M	10.5M

Cost Of Revenue Research Development

Yield10 Bioscience fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Property Plant And Equipment Gross
Total Assets		0.91	-0.03	-0.28	-0.3	0.25	0.71	-0.17	0.58	0.67	0.64	-0.08	0.86	-0.66	-0.15	0.71	0.3	0.34	0.93	0.57	0.31	0.89	0.05	0.29	0.36	-0.08
Total Stockholder Equity	0.91		-0.11	-0.27	-0.29	0.35	0.36	-0.22	0.65	0.6	0.27	-0.21	0.63	-0.68	-0.2	0.72	0.17	0.33	0.78	0.65	0.4	0.7	-0.28	0.45	0.46	-0.25
Retained Earnings	-0.03	-0.11		0.4	-0.55	-0.93	0.12	-0.55	0.15	0.34	0.24	-0.39	0.25	-0.37	0.49	0.3	-0.2	0.67	0.3	0.53	0.15	0.27	0.72	0.34	0.02	-0.48
Other Assets	-0.28	-0.27	0.4		-0.28	-0.41	-0.17	-0.18	-0.13	-0.16	-0.09	-0.1	-0.14	0.07	-0.01	-0.13	-0.1	0.36	-0.13	0.01	-0.1	-0.12	0.28	-0.07	0.02	-0.01
Common Stock Shares Outstanding	-0.3	-0.29	-0.55	-0.28		0.33	-0.2	0.31	-0.34	-0.2	-0.27	0.14	-0.24	0.6	0.3	-0.62	-0.06	-0.7	-0.4	-0.52	-0.37	-0.25	-0.28	-0.31	-0.35	0.51
Other Stockholder Equity	0.25	0.35	-0.93	-0.41	0.33		-0.05	0.45	0.0	-0.18	-0.16	0.32	-0.1	0.15	-0.62	-0.07	0.22	-0.49	-0.09	-0.32	-0.02	-0.09	-0.72	-0.21	0.13	0.39
Total Liab	0.71	0.36	0.12	-0.17	-0.2	-0.05		0.0	0.19	0.49	0.98	0.18	0.88	-0.33	-0.01	0.38	0.39	0.19	0.77	0.18	0.02	0.81	0.59	-0.13	0.03	0.25
Short Long Term Debt Total	-0.17	-0.22	-0.55	-0.18	0.31	0.45	0.0		-0.61	-0.52	-0.1	0.93	-0.25	0.71	-0.26	-0.59	0.73	-0.67	-0.35	-0.52	-0.38	-0.21	-0.18	-0.36	-0.31	0.51
Other Current Liab	0.58	0.65	0.15	-0.13	-0.34	0.0	0.19	-0.61		0.82	0.13	-0.7	0.41	-0.86	0.08	0.84	-0.44	0.64	0.52	0.78	0.6	0.38	-0.23	0.66	0.77	-0.56
Total Current Liabilities	0.67	0.6	0.34	-0.16	-0.2	-0.18	0.49	-0.52	0.82		0.44	-0.55	0.7	-0.73	0.43	0.7	-0.21	0.56	0.72	0.79	0.4	0.68	0.16	0.6	0.51	-0.34
Other Liab	0.64	0.27	0.24	-0.09	-0.27	-0.16	0.98	-0.1	0.13	0.44		0.12	0.85	-0.34	0.0	0.37	0.33	0.25	0.76	0.16	0.01	0.78	0.7	-0.18	-0.03	0.21
Property Plant And Equipment Net	-0.08	-0.21	-0.39	-0.1	0.14	0.32	0.18	0.93	-0.7	-0.55	0.12		-0.08	0.67	-0.31	-0.56	0.86	-0.59	-0.19	-0.51	-0.5	-0.03	0.07	-0.43	-0.45	0.55
Current Deferred Revenue	0.86	0.63	0.25	-0.14	-0.24	-0.1	0.88	-0.25	0.41	0.7	0.85	-0.08		-0.54	0.09	0.56	0.27	0.35	0.94	0.48	0.1	0.96	0.47	0.14	0.16	-0.03
Net Debt	-0.66	-0.68	-0.37	0.07	0.6	0.15	-0.33	0.71	-0.86	-0.73	-0.34	0.67	-0.54		0.07	-0.99	0.4	-0.72	-0.71	-0.77	-0.68	-0.52	-0.06	-0.52	-0.66	0.6
Accounts Payable	-0.15	-0.2	0.49	-0.01	0.3	-0.62	-0.01	-0.26	0.08	0.43	0.0	-0.31	0.09	0.07		-0.14	-0.17	0.09	0.04	0.27	-0.09	0.12	0.35	0.31	-0.23	-0.08
Cash	0.71	0.72	0.3	-0.13	-0.62	-0.07	0.38	-0.59	0.84	0.7	0.37	-0.56	0.56	-0.99	-0.14		-0.3	0.66	0.73	0.75	0.68	0.54	0.03	0.5	0.67	-0.57
Non Current Assets Total	0.3	0.17	-0.2	-0.1	-0.06	0.22	0.39	0.73	-0.44	-0.21	0.33	0.86	0.27	0.4	-0.17	-0.3		-0.28	0.21	-0.14	-0.39	0.36	0.15	-0.2	-0.36	0.42
Non Currrent Assets Other	0.34	0.33	0.67	0.36	-0.7	-0.49	0.19	-0.67	0.64	0.56	0.25	-0.59	0.35	-0.72	0.09	0.66	-0.28		0.49	0.74	0.55	0.37	0.3	0.48	0.52	-0.55
Cash And Short Term Investments	0.93	0.78	0.3	-0.13	-0.4	-0.09	0.77	-0.35	0.52	0.72	0.76	-0.19	0.94	-0.71	0.04	0.73	0.21	0.49		0.63	0.3	0.96	0.36	0.26	0.25	-0.15
Net Receivables	0.57	0.65	0.53	0.01	-0.52	-0.32	0.18	-0.52	0.78	0.79	0.16	-0.51	0.48	-0.77	0.27	0.75	-0.14	0.74	0.63		0.44	0.56	0.07	0.88	0.63	-0.57
Common Stock Total Equity	0.31	0.4	0.15	-0.1	-0.37	-0.02	0.02	-0.38	0.6	0.4	0.01	-0.5	0.1	-0.68	-0.09	0.68	-0.39	0.55	0.3	0.44		0.09	-0.17	0.24	0.55	-0.58
Short Term Investments	0.89	0.7	0.27	-0.12	-0.25	-0.09	0.81	-0.21	0.38	0.68	0.78	-0.03	0.96	-0.52	0.12	0.54	0.36	0.37	0.96	0.56	0.09		0.43	0.25	0.13	0.02
Non Current Liabilities Total	0.05	-0.28	0.72	0.28	-0.28	-0.72	0.59	-0.18	-0.23	0.16	0.7	0.07	0.47	-0.06	0.35	0.03	0.15	0.3	0.36	0.07	-0.17	0.43		-0.19	-0.3	0.1
Inventory	0.29	0.45	0.34	-0.07	-0.31	-0.21	-0.13	-0.36	0.66	0.6	-0.18	-0.43	0.14	-0.52	0.31	0.5	-0.2	0.48	0.26	0.88	0.24	0.25	-0.19		0.58	-0.45
Other Current Assets	0.36	0.46	0.02	0.02	-0.35	0.13	0.03	-0.31	0.77	0.51	-0.03	-0.45	0.16	-0.66	-0.23	0.67	-0.36	0.52	0.25	0.63	0.55	0.13	-0.3	0.58		-0.5
Property Plant And Equipment Gross	-0.08	-0.25	-0.48	-0.01	0.51	0.39	0.25	0.51	-0.56	-0.34	0.21	0.55	-0.03	0.6	-0.08	-0.57	0.42	-0.55	-0.15	-0.57	-0.58	0.02	0.1	-0.45	-0.5

Click cells to compare fundamentals

Yield10 Bioscience Account Relationship Matchups

Yield10 Bioscience fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	16.7M	14.5M	20.4M	8.1M	3.9M	3.7M
Total Stockholder Equity	(4.1M)	9.5M	16.0M	4.4M	(2.5M)	(2.4M)
Retained Earnings	(364.9M)	(375.1M)	(386.1M)	(399.7M)	(414.2M)	(393.4M)
Other Assets	650K	3.3M	547K	331K	380.7K	361.6K
Common Stock Shares Outstanding	365.0K	2.4M	4.7M	4.9M	7.9M	8.3M
Liabilities And Stockholders Equity	16.7M	14.5M	20.4M	8.1M	3.9M	3.7M
Other Stockholder Equity	344.2M	370.2M	402.3M	404.3M	411.8M	282.7M
Total Liab	20.8M	5.0M	4.4M	3.7M	6.4M	6.1M
Short Long Term Debt Total	4.2M	3.6M	3.2M	2.7M	3.2M	2.9M
Other Current Liab	1.3M	1.3M	1.1M	926K	2.0M	2.1M
Total Current Liabilities	2.2M	1.8M	1.7M	1.6M	4.9M	3.0M
Other Liab	935K	15.0M	13K	7K	6.3K	6.0K
Property Plant And Equipment Net	4.4M	3.6M	3.2M	2.7M	2.2M	2.3M
Net Debt	(1.2M)	197K	(2.2M)	294K	2.1M	2.2M
Accounts Payable	279K	60K	83K	109K	1.2M	1.3M
Cash	5.4M	3.4M	5.3M	2.4M	1.1M	1.0M
Non Current Assets Total	5.0M	4.2M	3.8M	3.1M	2.5M	2.9M
Non Currrent Assets Other	100K	318K	283K	67K	42K	39.9K
Cash And Short Term Investments	11.1M	9.7M	16.0M	4.3M	1.1M	1.0M
Net Receivables	92K	113K	198K	30K	27K	25.7K
Common Stock Total Equity	91K	100K	9K	33K	38.0K	36.1K
Non Current Liabilities Total	18.6M	3.2M	2.7M	2.1M	1.5M	1.4M
Other Current Assets	475K	527K	436K	641K	332K	315.4K
Property Plant And Equipment Gross	4.4M	3.6M	3.2M	2.7M	3.7M	2.2M
Total Current Assets	11.7M	10.3M	16.6M	5.0M	1.4M	1.3M
Accumulated Other Comprehensive Income	(126K)	(159K)	(175K)	(229K)	(265K)	(278.3K)
Short Term Debt	602K	457K	514K	575K	1.7M	1.7M
Common Stock	100K	9K	33K	49K	120K	185.2K
Property Plant Equipment	1.2M	3.6M	3.2M	2.7M	2.5M	1.9M
Net Tangible Assets	(4.1M)	9.5M	16.0M	4.4M	4.0M	3.8M
Retained Earnings Total Equity	(342.8M)	(351.9M)	(364.9M)	(375.1M)	(337.6M)	(354.5M)
Capital Surpluse	355.4M	357.6M	360.9M	384.8M	442.5M	365.5M
Non Current Liabilities Other	935K	18.6M	13K	7K	8.1K	7.6K
Capital Lease Obligations	4.2M	3.8M	3.2M	2.7M	2.2M	2.6M
Net Invested Capital	(4.1M)	9.5M	16.0M	4.4M	(1.5M)	(1.4M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
CRM	Salesforce
GOOG	Alphabet Inc Class C

When determining whether Yield10 Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Yield10 Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Yield10 Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Yield10 Bioscience Stock:

How To Invest In Yield10

Details

Is Yield10 Stock a good investment?

Details

What is Yield10 Bioscience's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Yield10 Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.

Note that the Yield10 Bioscience information on this page should be used as a complementary analysis to other Yield10 Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Yield10 Stock analysis

When running Yield10 Bioscience's price analysis, check to measure Yield10 Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Yield10 Bioscience is operating at the current time. Most of Yield10 Bioscience's value examination focuses on studying past and present price action to predict the probability of Yield10 Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Yield10 Bioscience's price. Additionally, you may evaluate how the addition of Yield10 Bioscience to your portfolios can decrease your overall portfolio volatility.

	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Transaction History View history of all your transactions and understand their impact on performance
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	CEOs Directory Screen CEOs from public companies around the world
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets

Is Yield10 Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Yield10 Bioscience. If investors know Yield10 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Yield10 Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.82)

Revenue Per Share

0.008

Quarterly Revenue Growth

(1.00)

Return On Assets

(1.50)

Return On Equity

(15.08)

The market value of Yield10 Bioscience is measured differently than its book value, which is the value of Yield10 that is recorded on the company's balance sheet. Investors also form their own opinion of Yield10 Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Yield10 Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Yield10 Bioscience's market value can be influenced by many factors that don't directly affect Yield10 Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Yield10 Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Yield10 Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Yield10 Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Yield10 Retained Earnings vs Long Term Investments Analysis

Retained Earnings vs Long Term Investments

Retained Earnings vs Long Term Investments Correlation Analysis

Correlation Coefficient

Retained Earnings

Long Term Investments

Yield10 Bioscience fundamental ratios Correlations

Yield10 Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Yield10 Bioscience fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Yield10 Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Liab	+ 0.98	Total Liab
Short Term Investments	+ 0.96	Current Deferred Revenue
Short Term Investments	+ 0.96	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.94	Current Deferred Revenue
Cash And Short Term Investments	+ 0.93	Total Assets
Property Plant And Equipment Net	+ 0.93	Short Long Term Debt Total

Cash	- 0.99	Net Debt
Other Stockholder Equity	- 0.93	Retained Earnings
Net Debt	- 0.86	Other Current Liab
Net Receivables	- 0.77	Net Debt
Net Debt	- 0.73	Total Current Liabilities
Non Currrent Assets Other	- 0.72	Net Debt